 Carl White
Concepts (536)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mustard Gas | 26 | 2024 | 117 | 5.820 |
Why?
| | Chemical Warfare Agents | 24 | 2024 | 121 | 4.810 |
Why?
| | Inhalation Exposure | 18 | 2020 | 102 | 3.630 |
Why?
| | Lung | 35 | 2024 | 3672 | 2.620 |
Why?
| | Airway Obstruction | 7 | 2020 | 168 | 2.510 |
Why?
| | Isocyanates | 5 | 2022 | 15 | 2.180 |
Why?
| | Epithelial Cells | 18 | 2020 | 961 | 1.840 |
Why?
| | Thromboplastin | 5 | 2022 | 71 | 1.660 |
Why?
| | Fibrinolytic Agents | 4 | 2016 | 233 | 1.620 |
Why?
| | Tissue Plasminogen Activator | 3 | 2020 | 228 | 1.390 |
Why?
| | Hyperoxia | 7 | 2022 | 97 | 1.380 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 8 | 2013 | 225 | 1.370 |
Why?
| | Rats, Sprague-Dawley | 21 | 2021 | 2262 | 1.210 |
Why?
| | Chlorine | 6 | 2018 | 62 | 1.190 |
Why?
| | Mechlorethamine | 10 | 2020 | 64 | 1.190 |
Why?
| | Skin | 17 | 2015 | 662 | 1.180 |
Why?
| | Respiratory Insufficiency | 4 | 2018 | 292 | 1.160 |
Why?
| | Antioxidants | 10 | 2016 | 533 | 1.140 |
Why?
| | Blood Coagulation | 3 | 2018 | 221 | 1.140 |
Why?
| | Vascular Endothelial Growth Factor A | 8 | 2022 | 503 | 1.130 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 7 | 2013 | 249 | 1.100 |
Why?
| | Rats | 22 | 2024 | 5034 | 1.040 |
Why?
| | Animals | 73 | 2024 | 32102 | 1.020 |
Why?
| | Bronchi | 6 | 2013 | 250 | 1.010 |
Why?
| | Hypoxia-Inducible Factor 1 | 4 | 2020 | 68 | 0.970 |
Why?
| | Thioredoxins | 4 | 2022 | 33 | 0.970 |
Why?
| | Oxidative Stress | 15 | 2016 | 1093 | 0.970 |
Why?
| | S-Adenosylmethionine | 5 | 2009 | 54 | 0.960 |
Why?
| | Respiratory Mucosa | 6 | 2017 | 258 | 0.960 |
Why?
| | Adenosine Triphosphate | 6 | 2015 | 431 | 0.940 |
Why?
| | Oxygen | 8 | 2022 | 837 | 0.920 |
Why?
| | Thioctic Acid | 3 | 2009 | 11 | 0.910 |
Why?
| | Antidotes | 8 | 2024 | 135 | 0.900 |
Why?
| | Ozone | 7 | 2020 | 99 | 0.850 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 3 | 2015 | 36 | 0.850 |
Why?
| | Endothelium, Vascular | 6 | 2013 | 845 | 0.850 |
Why?
| | Acute Lung Injury | 2 | 2016 | 300 | 0.800 |
Why?
| | Procollagen-Proline Dioxygenase | 6 | 2007 | 26 | 0.780 |
Why?
| | Vaping | 1 | 2022 | 46 | 0.780 |
Why?
| | Neovascularization, Physiologic | 5 | 2013 | 174 | 0.760 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2022 | 73 | 0.760 |
Why?
| | Air Pollutants | 3 | 2020 | 246 | 0.750 |
Why?
| | Toxicity Tests | 2 | 2018 | 28 | 0.740 |
Why?
| | Acetylcholine | 2 | 2011 | 180 | 0.710 |
Why?
| | Cell Survival | 14 | 2014 | 1024 | 0.710 |
Why?
| | Prostate | 2 | 2011 | 157 | 0.690 |
Why?
| | Premature Birth | 4 | 2007 | 278 | 0.670 |
Why?
| | Reactive Oxygen Species | 6 | 2016 | 549 | 0.660 |
Why?
| | Transcriptome | 2 | 2022 | 736 | 0.650 |
Why?
| | Hydantoins | 1 | 2018 | 5 | 0.640 |
Why?
| | Muscle Contraction | 2 | 2011 | 397 | 0.610 |
Why?
| | Endothelial Cells | 5 | 2020 | 695 | 0.600 |
Why?
| | Air Pollution | 1 | 2020 | 172 | 0.600 |
Why?
| | DNA Damage | 9 | 2015 | 357 | 0.590 |
Why?
| | Lung Diseases | 4 | 2017 | 710 | 0.590 |
Why?
| | Blotting, Western | 10 | 2020 | 1153 | 0.530 |
Why?
| | Cell Line | 12 | 2022 | 2651 | 0.530 |
Why?
| | Cystic Fibrosis | 5 | 2011 | 957 | 0.520 |
Why?
| | Cells, Cultured | 16 | 2015 | 3914 | 0.520 |
Why?
| | Factor VII | 2 | 2012 | 26 | 0.520 |
Why?
| | Bronchopulmonary Dysplasia | 4 | 2020 | 330 | 0.520 |
Why?
| | Fibrinolysis | 2 | 2014 | 160 | 0.520 |
Why?
| | Metalloporphyrins | 5 | 2016 | 106 | 0.510 |
Why?
| | Trachea | 6 | 2018 | 233 | 0.510 |
Why?
| | Cell Hypoxia | 5 | 2013 | 220 | 0.500 |
Why?
| | Bronchoalveolar Lavage Fluid | 7 | 2018 | 608 | 0.490 |
Why?
| | Amino Acids, Dicarboxylic | 4 | 2020 | 11 | 0.490 |
Why?
| | Apoptosis | 13 | 2015 | 2377 | 0.490 |
Why?
| | S-Adenosylhomocysteine | 3 | 2009 | 24 | 0.480 |
Why?
| | Trans-Activators | 3 | 2005 | 370 | 0.470 |
Why?
| | Bronchitis | 1 | 2014 | 37 | 0.460 |
Why?
| | Antifibrinolytic Agents | 1 | 2014 | 50 | 0.460 |
Why?
| | Household Articles | 1 | 2014 | 23 | 0.460 |
Why?
| | Thrombolytic Therapy | 1 | 2014 | 118 | 0.450 |
Why?
| | Disease Models, Animal | 11 | 2020 | 3580 | 0.450 |
Why?
| | Disinfectants | 1 | 2014 | 34 | 0.450 |
Why?
| | Mesna | 2 | 2024 | 17 | 0.440 |
Why?
| | Receptor, PAR-2 | 1 | 2012 | 8 | 0.430 |
Why?
| | Male | 36 | 2022 | 55949 | 0.420 |
Why?
| | Receptor, PAR-1 | 1 | 2012 | 21 | 0.420 |
Why?
| | Heparin | 1 | 2014 | 227 | 0.420 |
Why?
| | Neutrophils | 3 | 2013 | 1172 | 0.420 |
Why?
| | Dermatitis, Contact | 4 | 2013 | 24 | 0.410 |
Why?
| | Ethanolamines | 1 | 2012 | 20 | 0.410 |
Why?
| | Lipoproteins | 1 | 2013 | 162 | 0.410 |
Why?
| | Cell Proliferation | 10 | 2017 | 2194 | 0.410 |
Why?
| | Time Factors | 13 | 2016 | 6165 | 0.410 |
Why?
| | Fibrin | 4 | 2013 | 65 | 0.400 |
Why?
| | Mice, Hairless | 15 | 2015 | 74 | 0.400 |
Why?
| | Cholinergic Agonists | 1 | 2011 | 7 | 0.400 |
Why?
| | Receptor, Muscarinic M3 | 1 | 2011 | 3 | 0.400 |
Why?
| | Mecamylamine | 1 | 2011 | 8 | 0.390 |
Why?
| | Thinking | 1 | 2012 | 54 | 0.390 |
Why?
| | Budesonide | 1 | 2012 | 87 | 0.390 |
Why?
| | Nicotinic Antagonists | 1 | 2011 | 20 | 0.390 |
Why?
| | Heart Diseases | 1 | 2015 | 330 | 0.390 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 1098 | 0.390 |
Why?
| | Muscarinic Antagonists | 1 | 2011 | 27 | 0.390 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 24 | 0.380 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2013 | 239 | 0.380 |
Why?
| | Lung Injury | 4 | 2017 | 199 | 0.380 |
Why?
| | DNA Methylation | 2 | 2006 | 498 | 0.380 |
Why?
| | Nasal Cavity | 1 | 2011 | 47 | 0.380 |
Why?
| | Olfactory Mucosa | 1 | 2011 | 60 | 0.370 |
Why?
| | Vas Deferens | 1 | 2010 | 15 | 0.370 |
Why?
| | Asthma | 3 | 2020 | 2066 | 0.360 |
Why?
| | Dose-Response Relationship, Drug | 9 | 2018 | 1870 | 0.360 |
Why?
| | Methionine | 2 | 2008 | 145 | 0.360 |
Why?
| | Gases | 1 | 2010 | 38 | 0.360 |
Why?
| | Bronchodilator Agents | 1 | 2012 | 249 | 0.350 |
Why?
| | Inflammation | 6 | 2022 | 2499 | 0.350 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 2 | 2009 | 57 | 0.350 |
Why?
| | Administration, Inhalation | 5 | 2018 | 644 | 0.350 |
Why?
| | Receptors, Adenosine A2 | 1 | 2009 | 6 | 0.340 |
Why?
| | Transcription Factors | 4 | 2010 | 1528 | 0.340 |
Why?
| | Humans | 50 | 2022 | 115587 | 0.340 |
Why?
| | Models, Animal | 5 | 2017 | 350 | 0.330 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2015 | 400 | 0.330 |
Why?
| | Irritants | 3 | 2015 | 41 | 0.320 |
Why?
| | Cell Cycle | 3 | 2010 | 546 | 0.320 |
Why?
| | Environmental Exposure | 3 | 2020 | 378 | 0.320 |
Why?
| | Hypoxia | 3 | 2018 | 937 | 0.320 |
Why?
| | Exocytosis | 2 | 2006 | 89 | 0.310 |
Why?
| | Lung Diseases, Interstitial | 1 | 2014 | 520 | 0.310 |
Why?
| | Mice | 27 | 2022 | 15052 | 0.310 |
Why?
| | Respiratory Burst | 1 | 2008 | 28 | 0.310 |
Why?
| | NADP | 1 | 2008 | 42 | 0.300 |
Why?
| | Infant, Premature | 3 | 2010 | 477 | 0.300 |
Why?
| | Signal Transduction | 9 | 2022 | 4541 | 0.300 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 214 | 0.300 |
Why?
| | Papio | 6 | 2010 | 96 | 0.300 |
Why?
| | Deferoxamine | 1 | 2007 | 18 | 0.300 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2010 | 102 | 0.300 |
Why?
| | Metabolic Networks and Pathways | 1 | 2008 | 168 | 0.300 |
Why?
| | Suicidal Ideation | 1 | 2012 | 399 | 0.290 |
Why?
| | Bronchiolitis Obliterans | 2 | 2018 | 66 | 0.290 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1031 | 0.290 |
Why?
| | Immunohistochemistry | 8 | 2020 | 1642 | 0.290 |
Why?
| | Cobalt | 1 | 2007 | 46 | 0.290 |
Why?
| | Blister | 5 | 2014 | 43 | 0.290 |
Why?
| | Folic Acid | 1 | 2008 | 159 | 0.280 |
Why?
| | MAP Kinase Signaling System | 3 | 2015 | 275 | 0.280 |
Why?
| | Matrix Metalloproteinase 9 | 4 | 2022 | 117 | 0.280 |
Why?
| | Peroxidase | 9 | 2015 | 157 | 0.270 |
Why?
| | Phosphotransferases | 1 | 2006 | 25 | 0.270 |
Why?
| | Receptors, Purinergic | 1 | 2006 | 20 | 0.270 |
Why?
| | Tetrazolium Salts | 1 | 2006 | 18 | 0.270 |
Why?
| | Methionine Adenosyltransferase | 1 | 2005 | 10 | 0.260 |
Why?
| | Capillaries | 1 | 2006 | 92 | 0.260 |
Why?
| | Coloring Agents | 1 | 2006 | 71 | 0.260 |
Why?
| | Sputum | 2 | 2005 | 290 | 0.260 |
Why?
| | Leukocyte Elastase | 1 | 2005 | 79 | 0.250 |
Why?
| | Thiazoles | 1 | 2006 | 110 | 0.250 |
Why?
| | Enzyme Activation | 5 | 2013 | 793 | 0.250 |
Why?
| | Oxidation-Reduction | 7 | 2015 | 924 | 0.240 |
Why?
| | Cytoprotection | 2 | 2015 | 53 | 0.240 |
Why?
| | Recombinant Proteins | 4 | 2013 | 1243 | 0.240 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2018 | 125 | 0.240 |
Why?
| | Capillary Permeability | 3 | 2015 | 138 | 0.230 |
Why?
| | Respiratory Function Tests | 5 | 2020 | 535 | 0.230 |
Why?
| | Cell Line, Tumor | 6 | 2006 | 2751 | 0.230 |
Why?
| | Mental Disorders | 1 | 2012 | 902 | 0.230 |
Why?
| | Cytokines | 4 | 2016 | 1853 | 0.230 |
Why?
| | Phosphorylation | 8 | 2022 | 1571 | 0.230 |
Why?
| | Cystathionine | 1 | 2004 | 25 | 0.230 |
Why?
| | Cholesterol | 1 | 2006 | 369 | 0.230 |
Why?
| | Gene Expression Regulation | 4 | 2020 | 2353 | 0.230 |
Why?
| | Guanine | 1 | 2004 | 76 | 0.230 |
Why?
| | Sodium | 1 | 2024 | 183 | 0.220 |
Why?
| | Angiotensins | 1 | 2022 | 10 | 0.210 |
Why?
| | Hexokinase | 1 | 2002 | 10 | 0.210 |
Why?
| | Mesocricetus | 1 | 2022 | 30 | 0.210 |
Why?
| | Renin | 1 | 2022 | 31 | 0.210 |
Why?
| | Smoke | 1 | 2004 | 133 | 0.210 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2022 | 56 | 0.210 |
Why?
| | Limit of Detection | 2 | 2021 | 55 | 0.210 |
Why?
| | RNA, Small Interfering | 3 | 2013 | 544 | 0.200 |
Why?
| | Uncoupling Protein 2 | 1 | 2022 | 7 | 0.200 |
Why?
| | Cricetinae | 1 | 2022 | 260 | 0.200 |
Why?
| | Microdissection | 2 | 2013 | 15 | 0.200 |
Why?
| | Pesticides | 1 | 2022 | 49 | 0.200 |
Why?
| | Silymarin | 2 | 2015 | 194 | 0.200 |
Why?
| | Cotinine | 1 | 2022 | 68 | 0.200 |
Why?
| | Gene Knockdown Techniques | 2 | 2013 | 302 | 0.200 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2013 | 332 | 0.200 |
Why?
| | Animals, Newborn | 5 | 2020 | 780 | 0.190 |
Why?
| | Erythrocytes | 2 | 2018 | 589 | 0.190 |
Why?
| | Liver | 1 | 2009 | 1690 | 0.190 |
Why?
| | Mice, Knockout | 5 | 2022 | 2604 | 0.190 |
Why?
| | Prazosin | 2 | 2011 | 26 | 0.190 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 2 | 2011 | 18 | 0.190 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2021 | 477 | 0.190 |
Why?
| | Peptide PHI | 1 | 2020 | 4 | 0.190 |
Why?
| | Cobamides | 1 | 2020 | 19 | 0.180 |
Why?
| | Immunoglobulin M | 2 | 2013 | 254 | 0.180 |
Why?
| | Myocytes, Cardiac | 2 | 2015 | 457 | 0.180 |
Why?
| | Proteins | 3 | 2013 | 920 | 0.180 |
Why?
| | Cytotoxins | 1 | 2020 | 17 | 0.180 |
Why?
| | Superoxide Dismutase | 1 | 2022 | 332 | 0.180 |
Why?
| | Pregnancy, Animal | 1 | 2020 | 52 | 0.180 |
Why?
| | Hemoglobins | 1 | 2022 | 312 | 0.180 |
Why?
| | Fibrosis | 1 | 2022 | 457 | 0.180 |
Why?
| | Glutathione | 4 | 2011 | 303 | 0.180 |
Why?
| | Nicotine | 1 | 2022 | 266 | 0.170 |
Why?
| | DNA-Binding Proteins | 4 | 2014 | 1316 | 0.170 |
Why?
| | Transforming Growth Factor beta | 1 | 2022 | 446 | 0.170 |
Why?
| | Causality | 1 | 2020 | 106 | 0.170 |
Why?
| | Nitric Oxide Synthase Type II | 4 | 2014 | 160 | 0.170 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 414 | 0.170 |
Why?
| | In Vitro Techniques | 4 | 2020 | 1044 | 0.170 |
Why?
| | Mice, Inbred C57BL | 8 | 2022 | 4773 | 0.160 |
Why?
| | Societies, Medical | 2 | 2020 | 684 | 0.160 |
Why?
| | Sulfhydryl Compounds | 1 | 2020 | 178 | 0.160 |
Why?
| | Liquid-Liquid Extraction | 1 | 2018 | 15 | 0.160 |
Why?
| | Methylation | 2 | 2009 | 206 | 0.160 |
Why?
| | Particulate Matter | 1 | 2020 | 183 | 0.160 |
Why?
| | Plasminogen Activator Inhibitor 1 | 2 | 2018 | 82 | 0.160 |
Why?
| | DNA Repair | 2 | 2014 | 190 | 0.150 |
Why?
| | Enzyme Inhibitors | 3 | 2006 | 757 | 0.150 |
Why?
| | Lung Neoplasms | 3 | 2009 | 2207 | 0.150 |
Why?
| | Tumor Suppressor Protein p53 | 4 | 2015 | 449 | 0.150 |
Why?
| | Arterioles | 1 | 2017 | 40 | 0.150 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 795 | 0.150 |
Why?
| | Drug Interactions | 2 | 2011 | 347 | 0.150 |
Why?
| | Cardiac Output | 1 | 2018 | 143 | 0.150 |
Why?
| | Accidents, Occupational | 1 | 2017 | 15 | 0.150 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1137 | 0.140 |
Why?
| | Tomography, Optical Coherence | 1 | 2018 | 128 | 0.140 |
Why?
| | Cell Movement | 2 | 2013 | 867 | 0.140 |
Why?
| | DNA | 5 | 2010 | 1356 | 0.140 |
Why?
| | RNA, Messenger | 4 | 2009 | 2574 | 0.140 |
Why?
| | Biomarkers | 4 | 2022 | 3466 | 0.140 |
Why?
| | Necrosis | 2 | 2015 | 210 | 0.140 |
Why?
| | Alkylating Agents | 2 | 2013 | 27 | 0.140 |
Why?
| | Disaster Planning | 1 | 2017 | 77 | 0.130 |
Why?
| | Disasters | 1 | 2017 | 88 | 0.130 |
Why?
| | Calcium Signaling | 2 | 2015 | 211 | 0.130 |
Why?
| | Endoscopy | 1 | 2018 | 247 | 0.130 |
Why?
| | Cysteine | 2 | 2009 | 173 | 0.130 |
Why?
| | Stem Cell Transplantation | 1 | 2017 | 151 | 0.130 |
Why?
| | Polymerase Chain Reaction | 3 | 2013 | 1000 | 0.130 |
Why?
| | Etiocholanolone | 1 | 2015 | 7 | 0.130 |
Why?
| | Epidermis | 2 | 2014 | 149 | 0.130 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 2 | 2005 | 88 | 0.130 |
Why?
| | Cell Differentiation | 3 | 2017 | 1700 | 0.130 |
Why?
| | Ranolazine | 1 | 2015 | 22 | 0.130 |
Why?
| | Age Factors | 2 | 2020 | 2907 | 0.130 |
Why?
| | Glucose | 3 | 2005 | 904 | 0.130 |
Why?
| | Thiocyanates | 1 | 2015 | 29 | 0.120 |
Why?
| | Pulmonary Fibrosis | 1 | 2018 | 330 | 0.120 |
Why?
| | Hematopoietic System | 1 | 2014 | 8 | 0.120 |
Why?
| | alpha-2-Antiplasmin | 1 | 2014 | 3 | 0.120 |
Why?
| | Carboxypeptidase B2 | 1 | 2014 | 4 | 0.120 |
Why?
| | Reproducibility of Results | 2 | 2021 | 2800 | 0.120 |
Why?
| | Mitochondria, Heart | 1 | 2015 | 73 | 0.120 |
Why?
| | Blood-Air Barrier | 1 | 2014 | 10 | 0.120 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2006 | 157 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 495 | 0.120 |
Why?
| | Female | 16 | 2020 | 59913 | 0.120 |
Why?
| | Superoxides | 2 | 2022 | 215 | 0.120 |
Why?
| | Cardiotonic Agents | 1 | 2015 | 119 | 0.120 |
Why?
| | Cloning, Molecular | 2 | 2007 | 523 | 0.120 |
Why?
| | Drug Administration Routes | 1 | 2014 | 41 | 0.120 |
Why?
| | Thrombosis | 1 | 2017 | 302 | 0.120 |
Why?
| | Pulmonary Ventilation | 1 | 2014 | 68 | 0.120 |
Why?
| | Blood Coagulation Tests | 1 | 2014 | 57 | 0.120 |
Why?
| | Hyperkeratosis, Epidermolytic | 1 | 2014 | 20 | 0.120 |
Why?
| | Dermis | 1 | 2014 | 30 | 0.110 |
Why?
| | Metabolism, Inborn Errors | 1 | 2014 | 39 | 0.110 |
Why?
| | Transcriptional Activation | 2 | 2013 | 340 | 0.110 |
Why?
| | Kinetics | 2 | 2008 | 1569 | 0.110 |
Why?
| | Respiration | 1 | 2014 | 177 | 0.110 |
Why?
| | Intestine, Small | 1 | 2014 | 125 | 0.110 |
Why?
| | Cell Death | 2 | 2012 | 326 | 0.110 |
Why?
| | Pulmonary Alveoli | 2 | 2020 | 376 | 0.110 |
Why?
| | Acidosis | 1 | 2014 | 87 | 0.110 |
Why?
| | Pregnancy | 4 | 2020 | 5548 | 0.110 |
Why?
| | Prothrombin | 1 | 2013 | 22 | 0.110 |
Why?
| | Receptors, Purinergic P1 | 1 | 2013 | 23 | 0.110 |
Why?
| | Indicators and Reagents | 1 | 2013 | 100 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 285 | 0.110 |
Why?
| | Spleen | 1 | 2014 | 492 | 0.110 |
Why?
| | Primary Cell Culture | 1 | 2013 | 149 | 0.110 |
Why?
| | Random Allocation | 3 | 2020 | 337 | 0.110 |
Why?
| | Keratinocytes | 1 | 2014 | 215 | 0.110 |
Why?
| | Inflammation Mediators | 2 | 2016 | 479 | 0.100 |
Why?
| | Cyclooxygenase 2 | 4 | 2015 | 164 | 0.100 |
Why?
| | Adenoviridae | 1 | 2013 | 186 | 0.100 |
Why?
| | Drug Administration Schedule | 1 | 2014 | 724 | 0.100 |
Why?
| | Respiration, Artificial | 2 | 2007 | 526 | 0.100 |
Why?
| | Formoterol Fumarate | 1 | 2012 | 8 | 0.100 |
Why?
| | Fibrinogen | 1 | 2013 | 160 | 0.100 |
Why?
| | Stem Cells | 1 | 2017 | 546 | 0.100 |
Why?
| | Carbachol | 1 | 2011 | 21 | 0.100 |
Why?
| | Histones | 5 | 2015 | 540 | 0.100 |
Why?
| | Cell Culture Techniques | 1 | 2014 | 344 | 0.100 |
Why?
| | Skin Diseases | 1 | 2013 | 124 | 0.100 |
Why?
| | Factor Xa | 1 | 2011 | 32 | 0.100 |
Why?
| | Benzofurans | 1 | 2011 | 20 | 0.100 |
Why?
| | Milk Proteins | 1 | 2011 | 36 | 0.100 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 133 | 0.100 |
Why?
| | Pyrrolidines | 1 | 2011 | 56 | 0.100 |
Why?
| | Antigens, Surface | 1 | 2011 | 151 | 0.100 |
Why?
| | Body Weight | 2 | 2014 | 867 | 0.090 |
Why?
| | Cell Adhesion | 1 | 2012 | 433 | 0.090 |
Why?
| | Pneumonia | 1 | 2016 | 576 | 0.090 |
Why?
| | Algorithms | 1 | 2018 | 1490 | 0.090 |
Why?
| | GATA6 Transcription Factor | 1 | 2010 | 6 | 0.090 |
Why?
| | Immunoenzyme Techniques | 1 | 2011 | 193 | 0.090 |
Why?
| | Thiourea | 1 | 2010 | 39 | 0.090 |
Why?
| | Adrenergic alpha-1 Receptor Agonists | 1 | 2010 | 4 | 0.090 |
Why?
| | Atropine | 1 | 2010 | 31 | 0.090 |
Why?
| | Receptors, Purinergic P2X1 | 1 | 2010 | 4 | 0.090 |
Why?
| | Child | 3 | 2020 | 18488 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 930 | 0.090 |
Why?
| | Mitochondria | 2 | 2008 | 750 | 0.090 |
Why?
| | Receptors, Adrenergic, alpha-1 | 1 | 2010 | 41 | 0.090 |
Why?
| | Wound Healing | 1 | 2012 | 257 | 0.090 |
Why?
| | Accidents | 1 | 2010 | 40 | 0.090 |
Why?
| | Organ Culture Techniques | 1 | 2010 | 143 | 0.090 |
Why?
| | Comet Assay | 2 | 2014 | 18 | 0.090 |
Why?
| | Myocardium | 1 | 2015 | 926 | 0.090 |
Why?
| | Models, Biological | 2 | 2008 | 1646 | 0.090 |
Why?
| | Dermatitis, Irritant | 1 | 2009 | 11 | 0.090 |
Why?
| | Electric Stimulation | 1 | 2010 | 263 | 0.090 |
Why?
| | Peptides | 1 | 2015 | 864 | 0.090 |
Why?
| | Muscle, Smooth | 1 | 2010 | 150 | 0.090 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2011 | 288 | 0.080 |
Why?
| | Microscopy, Confocal | 1 | 2010 | 299 | 0.080 |
Why?
| | Drug Therapy, Combination | 1 | 2012 | 962 | 0.080 |
Why?
| | Luciferases | 1 | 2009 | 140 | 0.080 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2009 | 129 | 0.080 |
Why?
| | Response Elements | 1 | 2009 | 83 | 0.080 |
Why?
| | Biomarkers, Pharmacological | 1 | 2008 | 26 | 0.080 |
Why?
| | Peroxides | 1 | 2008 | 20 | 0.080 |
Why?
| | Mitochondrial Membranes | 1 | 2008 | 32 | 0.080 |
Why?
| | Skinfold Thickness | 3 | 2013 | 48 | 0.080 |
Why?
| | Disulfides | 1 | 2008 | 91 | 0.080 |
Why?
| | Methyltransferases | 1 | 2008 | 61 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2010 | 286 | 0.080 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2008 | 37 | 0.080 |
Why?
| | Nanoparticles | 1 | 2011 | 316 | 0.070 |
Why?
| | Kidney | 1 | 2014 | 1207 | 0.070 |
Why?
| | Infant, Newborn | 4 | 2010 | 5077 | 0.070 |
Why?
| | Occupational Exposure | 1 | 2010 | 262 | 0.070 |
Why?
| | RNA Interference | 1 | 2009 | 438 | 0.070 |
Why?
| | Calcium | 1 | 2013 | 1103 | 0.070 |
Why?
| | Fluorescent Antibody Technique | 2 | 2011 | 398 | 0.070 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2007 | 14 | 0.070 |
Why?
| | Demecolcine | 1 | 2006 | 2 | 0.070 |
Why?
| | DNA-Cytosine Methylases | 1 | 2006 | 5 | 0.070 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2007 | 104 | 0.070 |
Why?
| | Immediate-Early Proteins | 1 | 2007 | 53 | 0.070 |
Why?
| | Endoplasmic Reticulum | 1 | 2009 | 235 | 0.070 |
Why?
| | Fibroblasts | 1 | 2011 | 839 | 0.070 |
Why?
| | Mucins | 1 | 2007 | 61 | 0.070 |
Why?
| | Stilbenes | 1 | 2006 | 36 | 0.070 |
Why?
| | Mice, Inbred BALB C | 3 | 2015 | 1168 | 0.070 |
Why?
| | United States | 2 | 2020 | 12295 | 0.070 |
Why?
| | Solubility | 1 | 2007 | 226 | 0.070 |
Why?
| | Cell Cycle Proteins | 1 | 2010 | 553 | 0.070 |
Why?
| | Arabidopsis Proteins | 1 | 2007 | 65 | 0.070 |
Why?
| | Receptors, Purinergic P2 | 1 | 2006 | 20 | 0.070 |
Why?
| | Analysis of Variance | 2 | 2008 | 1227 | 0.070 |
Why?
| | Adult | 3 | 2020 | 30718 | 0.070 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2007 | 185 | 0.070 |
Why?
| | Fetus | 2 | 2010 | 702 | 0.070 |
Why?
| | Computer Systems | 1 | 2006 | 46 | 0.070 |
Why?
| | Arabidopsis | 1 | 2007 | 79 | 0.070 |
Why?
| | Apolipoprotein A-I | 1 | 2006 | 25 | 0.070 |
Why?
| | Bacterial Infections | 1 | 2008 | 222 | 0.070 |
Why?
| | Xanthine Oxidase | 1 | 2006 | 72 | 0.070 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 68 | 0.060 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 36 | 0.060 |
Why?
| | Vasa Vasorum | 1 | 2005 | 33 | 0.060 |
Why?
| | Brefeldin A | 1 | 2005 | 15 | 0.060 |
Why?
| | Cinnamates | 1 | 2005 | 10 | 0.060 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2006 | 181 | 0.060 |
Why?
| | Transduction, Genetic | 1 | 2005 | 114 | 0.060 |
Why?
| | Apyrase | 1 | 2005 | 14 | 0.060 |
Why?
| | Egtazic Acid | 1 | 2005 | 44 | 0.060 |
Why?
| | Oxygen Consumption | 1 | 2008 | 573 | 0.060 |
Why?
| | Pyrophosphatases | 1 | 2005 | 22 | 0.060 |
Why?
| | Deoxyglucose | 1 | 2005 | 43 | 0.060 |
Why?
| | Mucin-5B | 1 | 2007 | 185 | 0.060 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1122 | 0.060 |
Why?
| | Rad51 Recombinase | 2 | 2015 | 14 | 0.060 |
Why?
| | Isoenzymes | 1 | 2005 | 285 | 0.060 |
Why?
| | Hydrolysis | 1 | 2005 | 179 | 0.060 |
Why?
| | Administration, Cutaneous | 2 | 2015 | 116 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 147 | 0.060 |
Why?
| | Mice, Transgenic | 2 | 2022 | 1970 | 0.060 |
Why?
| | Sheep | 1 | 2007 | 764 | 0.060 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2005 | 130 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 165 | 0.060 |
Why?
| | Amino Acids, Sulfur | 1 | 2004 | 8 | 0.060 |
Why?
| | Escherichia coli Proteins | 1 | 2005 | 164 | 0.060 |
Why?
| | Gestational Age | 1 | 2007 | 757 | 0.060 |
Why?
| | Gene Expression | 1 | 2009 | 1435 | 0.060 |
Why?
| | Deoxyguanosine | 2 | 2015 | 26 | 0.060 |
Why?
| | Tumor Cells, Cultured | 1 | 2005 | 850 | 0.060 |
Why?
| | Neovascularization, Pathologic | 1 | 2005 | 283 | 0.060 |
Why?
| | Viscosity | 1 | 2003 | 82 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 804 | 0.060 |
Why?
| | Actins | 1 | 2005 | 383 | 0.060 |
Why?
| | Rheology | 1 | 2003 | 88 | 0.060 |
Why?
| | Adenosine | 1 | 2005 | 203 | 0.060 |
Why?
| | Homeodomain Proteins | 1 | 2007 | 465 | 0.050 |
Why?
| | Elasticity | 1 | 2003 | 194 | 0.050 |
Why?
| | Flow Cytometry | 1 | 2006 | 1083 | 0.050 |
Why?
| | Pronase | 1 | 2022 | 5 | 0.050 |
Why?
| | DNA, Single-Stranded | 1 | 2004 | 110 | 0.050 |
Why?
| | Edema | 2 | 2013 | 119 | 0.050 |
Why?
| | Electric Impedance | 2 | 2014 | 99 | 0.050 |
Why?
| | Carbamates | 1 | 2022 | 35 | 0.050 |
Why?
| | Neutrophil Infiltration | 2 | 2015 | 95 | 0.050 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2022 | 23 | 0.050 |
Why?
| | Carcinoma | 1 | 2004 | 200 | 0.050 |
Why?
| | Adaptation, Physiological | 1 | 2006 | 476 | 0.050 |
Why?
| | Angiogenesis Inhibitors | 1 | 2004 | 216 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2022 | 42 | 0.050 |
Why?
| | Macrophages, Peritoneal | 1 | 2002 | 93 | 0.050 |
Why?
| | Staining and Labeling | 1 | 2002 | 139 | 0.050 |
Why?
| | Organ Size | 2 | 2014 | 434 | 0.050 |
Why?
| | Oxidants | 1 | 2002 | 112 | 0.050 |
Why?
| | Membrane Potentials | 1 | 2002 | 251 | 0.050 |
Why?
| | Phenols | 1 | 2022 | 82 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2009 | 3022 | 0.050 |
Why?
| | Tyrosine | 1 | 2022 | 219 | 0.050 |
Why?
| | Phosphatidylcholines | 1 | 2002 | 134 | 0.050 |
Why?
| | Pulmonary Surfactants | 1 | 2002 | 101 | 0.050 |
Why?
| | Drug Stability | 1 | 2021 | 152 | 0.050 |
Why?
| | Cell Division | 1 | 2003 | 759 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 263 | 0.050 |
Why?
| | Hydrogen Peroxide | 1 | 2002 | 287 | 0.050 |
Why?
| | Serotonin | 1 | 2003 | 296 | 0.050 |
Why?
| | Injections, Intralesional | 1 | 2020 | 32 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2004 | 385 | 0.050 |
Why?
| | RNA-Binding Proteins | 1 | 2004 | 362 | 0.050 |
Why?
| | Tissue Culture Techniques | 1 | 2020 | 67 | 0.050 |
Why?
| | Injections, Intramuscular | 1 | 2020 | 118 | 0.050 |
Why?
| | Chronic Disease | 1 | 2006 | 1598 | 0.040 |
Why?
| | Aldehydes | 2 | 2012 | 144 | 0.040 |
Why?
| | Escherichia coli | 1 | 2003 | 730 | 0.040 |
Why?
| | Disease Progression | 3 | 2014 | 2418 | 0.040 |
Why?
| | Endotoxins | 1 | 2020 | 207 | 0.040 |
Why?
| | Linear Models | 1 | 2021 | 776 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2007 | 2578 | 0.040 |
Why?
| | Mast Cells | 2 | 2011 | 117 | 0.040 |
Why?
| | Reference Values | 1 | 2020 | 744 | 0.040 |
Why?
| | Pulmonary Circulation | 1 | 2020 | 407 | 0.040 |
Why?
| | Mutation | 1 | 2009 | 3364 | 0.040 |
Why?
| | Swine | 1 | 2020 | 704 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2018 | 82 | 0.040 |
Why?
| | Prenatal Care | 1 | 2020 | 257 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 40 | 0.040 |
Why?
| | Hypercapnia | 1 | 2018 | 50 | 0.040 |
Why?
| | Chemical Terrorism | 1 | 2017 | 5 | 0.040 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2018 | 156 | 0.040 |
Why?
| | Platelet Aggregation | 1 | 2017 | 94 | 0.040 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2017 | 81 | 0.040 |
Why?
| | Airway Remodeling | 1 | 2017 | 60 | 0.040 |
Why?
| | NF-kappa B | 2 | 2011 | 639 | 0.030 |
Why?
| | Interleukin-8 | 2 | 2011 | 241 | 0.030 |
Why?
| | Naphthalenes | 1 | 2017 | 39 | 0.030 |
Why?
| | Receptors, Notch | 1 | 2017 | 85 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2017 | 137 | 0.030 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 101 | 0.030 |
Why?
| | Epithelium | 1 | 2017 | 297 | 0.030 |
Why?
| | Skin Absorption | 1 | 2015 | 13 | 0.030 |
Why?
| | Mucus | 1 | 2015 | 55 | 0.030 |
Why?
| | Neuropeptides | 1 | 2015 | 65 | 0.030 |
Why?
| | Acute Disease | 1 | 2018 | 914 | 0.030 |
Why?
| | Cell Lineage | 1 | 2017 | 310 | 0.030 |
Why?
| | Serum Albumin | 1 | 2015 | 135 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2015 | 138 | 0.030 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 114 | 0.030 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2014 | 11 | 0.030 |
Why?
| | Chemokines | 1 | 2015 | 214 | 0.030 |
Why?
| | Peptide Hydrolases | 1 | 2015 | 109 | 0.030 |
Why?
| | Chromones | 1 | 2014 | 35 | 0.030 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2014 | 41 | 0.030 |
Why?
| | Boron Compounds | 1 | 2014 | 17 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1024 | 0.030 |
Why?
| | Tetraspanin 24 | 1 | 2013 | 5 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2014 | 294 | 0.030 |
Why?
| | Integrin alpha6 | 1 | 2013 | 8 | 0.030 |
Why?
| | Chemokine CXCL5 | 1 | 2013 | 12 | 0.030 |
Why?
| | Chemokine CXCL1 | 1 | 2013 | 66 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2015 | 274 | 0.030 |
Why?
| | Weight Loss | 1 | 2018 | 633 | 0.030 |
Why?
| | Morpholines | 1 | 2014 | 103 | 0.030 |
Why?
| | Erythema | 1 | 2013 | 25 | 0.030 |
Why?
| | Clone Cells | 1 | 2013 | 248 | 0.030 |
Why?
| | Keratins | 1 | 2013 | 176 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2013 | 129 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2010 | 794 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2006 | 9159 | 0.030 |
Why?
| | Species Specificity | 1 | 2013 | 552 | 0.030 |
Why?
| | Cyclic AMP | 1 | 2013 | 227 | 0.030 |
Why?
| | Regeneration | 1 | 2013 | 162 | 0.030 |
Why?
| | Chromans | 1 | 2011 | 21 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1219 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2011 | 194 | 0.020 |
Why?
| | Down-Regulation | 1 | 2013 | 601 | 0.020 |
Why?
| | Buthionine Sulfoximine | 1 | 2010 | 8 | 0.020 |
Why?
| | Dermatitis | 1 | 2010 | 17 | 0.020 |
Why?
| | Bronchoalveolar Lavage | 1 | 2010 | 89 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 820 | 0.020 |
Why?
| | Alleles | 1 | 2013 | 794 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2011 | 511 | 0.020 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2010 | 63 | 0.020 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2010 | 88 | 0.020 |
Why?
| | Homeostasis | 1 | 2013 | 577 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2010 | 107 | 0.020 |
Why?
| | Deoxyadenosines | 1 | 2009 | 7 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2009 | 26 | 0.020 |
Why?
| | Cyclic N-Oxides | 1 | 2009 | 30 | 0.020 |
Why?
| | Acetylcysteine | 1 | 2010 | 144 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2014 | 594 | 0.020 |
Why?
| | Protein Binding | 1 | 2015 | 1917 | 0.020 |
Why?
| | Transcription Factor AP-1 | 1 | 2009 | 82 | 0.020 |
Why?
| | Caspase 3 | 1 | 2010 | 237 | 0.020 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2008 | 49 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2011 | 401 | 0.020 |
Why?
| | Oxidative Phosphorylation | 1 | 2009 | 156 | 0.020 |
Why?
| | Administration, Topical | 1 | 2008 | 137 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1536 | 0.020 |
Why?
| | Phenotype | 1 | 2013 | 2829 | 0.020 |
Why?
| | Adolescent | 1 | 2003 | 17889 | 0.020 |
Why?
| | RNA | 1 | 2010 | 819 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2004 | 298 | 0.010 |
Why?
| | Cattle | 1 | 2002 | 935 | 0.010 |
Why?
| | Monocytes | 1 | 2002 | 507 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2002 | 645 | 0.010 |
Why?
| | Infant | 1 | 2004 | 7979 | 0.010 |
Why?
|
|
White's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|